Bacterial strains including B. breve BbIBS01 (DSM 33231), B. breve BbIBS02 (DSM 33232), B. animalis subsp. lactis BIIBS01 (DSM 33233) and L. plantarum LpIBS01 (DSM 33234) are described. Furthermore, compositions are further described comprising a mixture of at least one or more of the aforementioned bacterial strains and, optionally, at least one further bacterial strain, selected from a bacterial strain L. casei DG® (CNCM I-1572) and bacterial strain L. paracasei LPC-S01™ (DSM 26760) and related method for the treatment of gastrointestinal diseases, disorders or symptoms, in particular functional gastrointestinal disorders, such as, irritable bowel syndrome (IBS).

A particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention is isolated from excrement of a human or cabbage kimchi, and thus is highly safe and has physiological activities such as an immunity regulatory effect and an inflammation reaction inhibiting effect. Therefore, the particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention may be used as a material for regulating immunity and inhibiting inflammation reactions, and may be also used as a functional food and drug material useful for preventing, alleviating or treating rhinitis, atopy, asthma, etc. which are allergic diseases.

Provided is a novel Lactobacillus Plantarum strain and a composition for preventing or treating a metabolic disease including the same. A Lactobacillus Plantarum (Accession No. KCTC 14107BP) according to the present invention may inhibit fat accumulation in white adipose tissue, brown adipose tissue, and liver tissue. The Lactobacillus Plantarum strain may exhibit excellent blood glucose improvement effect, and in particular, may reduce a fasting blood glucose level. The Lactobacillus Plantarum strain may effectively ameliorate insulin resistance by improving glucose tolerance and increasing insulin sensitivity. In addition, the Lactobacillus Plantarum strain may regulate a concentration of metabolic hormones in blood. Therefore, the Lactobacillus Plantarum strain may be usefully used to prevent or treat a metabolic disease.

The disclosure provides novel microorganisms, such as Lactobacillus sp., Bifidobacterium sp., and Veillonella sp., and compositions thereof for improving athletic performance, enhancing exercise endurance, improving physical recovery from exercise, and reducing inflammation in a subject in need thereof.

The present invention relates to a Lactobacillus spp. selective prebiotic composition comprising one, or a mixture of two or more, of: xylooligosaccharides, cellobiose and/or gentiooligosaccharides. The present invention also relates to a synbiotic composition comprising a probiotic component comprising one or more strains of Lactobacillus rhamnosus and/or one or more strains of Lactobacillus plantarum and a prebiotic component comprising a growth medium which is specific for the growth of the probiotic component, wherein the prebiotic growth medium comprises one or more, or a mixture of two of more, components selected from: xylooligosaccharides, cellobiose and/or gentiooligosaccharides. The present invention also relates to methods of producing and selecting such compositions.

The invention relates to the use of at least one strain of Lactobacillus plantarum to increase vigour in a human.

The present invention relates to a cosmetic composition for preventing or improving aging that comprises a culture of one or more lactic acid bacteria selected from a group consisting of Lactobacillus plantarum Wikim 125 (Access No. BP1910798) isolated from Kimchi and Lactobacillus plantarum Wikim 126 (Access No. BP1910799) and the Lactobacillus plantarum Wikim 127 (Access No. BP1910800) that are isolated from Sauerkraut and may further comprise a dead cell of one or more lactic acid bacteria selected from the group. The cosmetic composition for preventing or improving aging of the present invention can promote skin aging improvement effects through antioxidation, inflammation relief, moisturizing enhancement, skin tone improvement, elasticity and wrinkle improvement, by using natural derived lactic acid bacteria that are skin-friendly, safe, and capable of improving skin functions and cultures using these lactic acid bacteria.

Disclosed herein is use of a culture of at least one lactic acid bacterial strain for alleviating a Helicobacter pylori-associated disorder. The at least one lactic acid bacterial strain is selected from the group consisting of Lactobacillus rhamnosus F-1 which is deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011124, Lactobacillus plantarum LPL28 which is deposited at the China General Microbiological Culture Collection Center (CGMCC) under an accession number CGMCC 17954, and Lactobacillus acidophilus TYCA06 which is deposited at the CGMCC under an accession number CGMCC 15210.

A method for producing γ-aminobutyric acid includes cultivating, in a culture medium containing glutamic acid or a salt thereof, a probiotic composition including at least one lactic acid bacterial strain selected from the group consisting of Bifidobacterium breve CCFM1025 which is deposited at the Guangdong Microbial Culture Collection Center under an accession number GDMCC 60386, Lactobacillus acidophilus TYCA06, Lactobacillus plantarum LPL28, and Bifidobacterium longum subsp. infantis BLI-02 which are deposited at the China General Microbiological Culture Collection Center respectively under accession numbers CGMCC 15210, CGMCC 17954, and CGMCC 15212, Lactobacillus salivarius subsp. salicinius AP-32 which is deposited at the China Center for Type Culture Collection under an accession number CCTCC M 2011127, and combinations thereof.

Provided are a microorganism selected from the group consisting of Lactobacillus salivarius LMT15-14 (Accession No. KCTC14142BP) and Lactobacillus plantarum LMT19-1 (Accession No. KCTC14141BP) or a combination thereof or a culture or extract thereof, and a use thereof.